NCT02725242View on ClinicalTrials.gov

Efficacy of Once-daily Budesonide/Formoterol Turbuhaler 4.5/160 µg in Step Down Asthma

PHASE3CompletedINTERVENTIONAL
Enrollment

77

Participants

Timeline

Start Date

March 31, 2016

Primary Completion Date

December 31, 2016

Study Completion Date

December 31, 2016

Conditions
Asthma
Interventions
DRUG

Budesonide/formoterol (160/4.5 μg/d)

After the patients who have all criteria, they will be randomization to take Budesonide/formoterol (160/4.5 μg/d)

DRUG

Budesonide (400μg/d)

After the patients who have all criteria, they will be randomization to take Budesonide (200 ug) twice daily

Trial Locations (1)

90110

Narongwit Nakwan, Hat Yai

All Listed Sponsors
lead

Hat Yai Medical Education Center

OTHER

NCT02725242 - Efficacy of Once-daily Budesonide/Formoterol Turbuhaler 4.5/160 µg in Step Down Asthma | Biotech Hunter | Biotech Hunter